Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This study was designed to test the safety and effectiveness of EPZICOM(abacavir/lamivudine)
and TRUVADA (emtricitabine/tenofovir) for the treatment of HIV infection when both are used
in combination with KALETRA (lopinavir/ritonavir) over 96 weeks